重慶銀行(01963.HK)股東未披露悉售持股遭中證監警示
重慶銀行(01963.HK)公布,股東交通融資擔保收到中國證監會重慶監管局警示函,指其於今年2月通過集中競價交易方式減持股份,未按規定提前15個交易日履行減持預披露義務,減持完畢後也未及時披露,違反了《上市公司信息披露管理辦法》、《上市公司股東、董監高減持股份的若干規定》的相關規定,因此決定對交通融資擔保採取出具警示函的行政監管措施。
截至今年2月15日,交通融資擔保公司持有重慶銀行股份約405萬股,佔公司總股本0.12%。該公司於今年2月16日至3月2日期間,通過集中競價交易方式減持所持有的全部重慶銀行股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.